Deena M.A. Gendoo

About Deena M.A. Gendoo

Deena M.A. Gendoo, With an exceptional h-index of 17 and a recent h-index of 15 (since 2020), a distinguished researcher at University of Birmingham, specializes in the field of Bioinformatics, Computational Biology, Cancer, Disease Models, Pharmacogenomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Circulating tumour DNA detects somatic variants contributing to spatial and temporal intratumoural heterogeneity in head and neck squamous cell carcinoma

A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Overview of Bioinformatics Software and Databases for Metabolic Engineering

The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress

The cell cycle state defines TACC3 as a regulator gene in glioblastoma

Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy

Deena M.A. Gendoo Information

University

Position

Associate Professor in Computational Biology

Citations(all)

1723

Citations(since 2020)

1287

Cited By

1015

hIndex(all)

17

hIndex(since 2020)

15

i10Index(all)

22

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Deena M.A. Gendoo Skills & Research Interests

Bioinformatics

Computational Biology

Cancer

Disease Models

Pharmacogenomics

Top articles of Deena M.A. Gendoo

Circulating tumour DNA detects somatic variants contributing to spatial and temporal intratumoural heterogeneity in head and neck squamous cell carcinoma

Frontiers in Oncology

2024/4/9

A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements

Genome Research

2023/2/1

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Nature Communications

2022/10/24

Overview of Bioinformatics Software and Databases for Metabolic Engineering

2022/10/14

The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress

Cancer Letters

2021/3/31

The cell cycle state defines TACC3 as a regulator gene in glioblastoma

bioRxiv

2020/10/20

Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies

bioRxiv

2020/9/9

Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy

Nature communications

2020/4/14

A common analgesic enhances the anti-tumour activity of 5-aza-2’-deoxycytidine through induction of oxidative stress

bioRxiv

2020/4/1

The common analgesic paracetamol enhances the anti-tumour activity of decitabine through exacerbation of oxidative stress

2020/4/1

Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research

2020/1/1

See List of Professors in Deena M.A. Gendoo University(University of Birmingham)

Co-Authors

academic-engine